Gilead Sciences Inc
Stock Chart, Company Information, and Scan Results
$133.48(as of May 5, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Gilead Sciences Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$133.48
Ticker SymbolGILD
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees17,000
CountyUSA
Market Cap$164,695.3M
EBIDTA14,577.0M
10-Day Moving Average131.15
P/E Ratio19.65
20-Day Moving Average134.93
Forward P/E Ratio15.06
50-Day Moving Average139.41
Earnings per Share6.83
200-Day Moving Average125.92
Profit Margin27.55%
RSI45.48
Shares Outstanding1,241.2M
ATR3.06
52-Week High156.40
Volume5,957,306
52-Week Low92.83
Book Value22,618.0M
P/B Ratio7.39
Upper Keltner141.81
P/S Ratio5.68
Lower Keltner128.06
Debt-to-Equity Ratio141.81
Next Earnings DateUnknown
Cash Surplus-4,249.0M
Next Ex-Dividend DateUnknown
Add good karma to your portfolio with GILD. This research-based biopharmaceutical company is making the world a better place by developing and commercializing medicines for life-threatening diseases like HIV/AIDS, liver diseases, and cancer. Gilead’s HIV treatments, including Truvada and Atripla, have helped transform the chronic disease into a manageable condition. Their treatments are responsible for saving millions of lives.
Gilead Sciences Inc In Our Stock Scanner
As of May 06, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.